All comparisons
GILD vs MRNA
Gilead Sciences, Inc. vs Moderna, Inc.
Overview
GILDGilead Sciences, Inc.
Score APrice
$159.20
Fair Value
$183.33
Upside
+15.2%
Convex Score
10/10
MRNAModerna, Inc.
Score D (Speculative)Price
$214.17
Fair Value
$75.36
Upside
-64.8%
Convex Score
1/10
Valuation
GILD
Bear$143.28
Base$258.10
Bull$360.22
Fair Value$183.33
MRNA
Bear$45.22
Base$75.36
Bull$105.50
Fair Value$75.36
Quality
GILD
Grade
C
Score
72/100
Classification
Blue Chip
Rating
Score A
MRNA
Grade
D
Score
42/100
Classification
Compounder
Rating
Score D (Speculative)
Company Info
| GILD | MRNA | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Biotechnology |
| Classification | Blue Chip | Compounder |
Verdict
GILD has better risk/reward
GILD: Higher upside potentialGILD: Higher Convex ScoreGILD: Better quality grade